Wednesday, June 20, 2007

Pfizer Receives Approvable Letter For Maraviroc. Investigation Continues.

Pfizer just announced that the U.S. Food and Drug Administration (FDA) issued an approvable letter for maraviroc, as a therapy for HIV patients. Labeling is not yet finalized.

Pfizer did not comment on the ongoing investigation related to unapproved marketing allegations by a sales rep.

You can read that story here.

1 comment:

Anonymous said...

Now they can make it legal...once they submit their marketing plan ha ha ha ha we have the slides so we already know what it is more of the same off label, unbranded promotion of an almost approved drug. Oh well they always win $$$$$